Reading planners from Barton Willmore have secured planning on behalf of Proton Partners International, for a £30 million cancer treatment centre at Thames Valley Science Park in Reading. The team were instructed in September 2016 to submit a detailed reserved matters application on behalf of both Proton Partners International and the University of Reading, submitting the application in October 2016. The scheme received unanimous support and permission was granted on 7 December 2016.
The Proton Therapy centre will offer a pioneering form of treatment, including proton beam therapy, and will help around 500 patients each year. The centre will be the third to be built in the UK by Proton Partners International and offers a specialised type of cancer treatment that is not yet available in the UK. Two other centres are currently under construction, the first in Newport, Wales and the second will be in Bomarsund, Northumberland.
It is expected that each Proton Partners centre will be able to treat up to 500 patients a year and will accept NHS patients, medically-insured private patients and self-paying patients.
The Thames Valley Science Park is part of The University of Reading’s plans to build a science park which aims to create up to 5,000 jobs and provide 800,000 sq ft of innovative, knowledge and technology based organisations, that seek to exchange ideas and collaborate with each other, the University and other research centres.
During December 2016, our team also submitted an outline planning application for 600,000 sq ft of space to comprise Phase 2 of the Thames Valley Science Park. A decision is excepted during 2017.
Posted with the following keywords:
Thames Valley, Healthcare, Reading, Thames Valley Science Park